Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study ; volume:21 ; number:1 ; day:14 ; month:8 ; year:2021 ; pages:1-8 ; date:12.2021
BMC ophthalmology ; 21, Heft 1 (14.8.2021), 1-8, 12.2021
- Creator
-
Corazza, Paolo
D’Alterio, Francesco Maria
Kabbani, Jamil
Alam, Mostafa Mohamed Ragheb
Mercuri, Stefano
Orlans, Harry Otway
Younis, Saad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-021-02055-6
- URN
-
urn:nbn:de:101:1-2021110319521574587951
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Corazza, Paolo
- D’Alterio, Francesco Maria
- Kabbani, Jamil
- Alam, Mostafa Mohamed Ragheb
- Mercuri, Stefano
- Orlans, Harry Otway
- Younis, Saad
- SpringerLink (Online service)
Other Objects (12)
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture